322 related articles for article (PubMed ID: 12462298)
1. Preliminary results of a nonrandomized, multicenter, open-label study of patient satisfaction after treatment with combination benzoyl peroxide/clindamycin topical gel for mild to moderate acne.
Weiss JW; Shavin J; Davis M
Clin Ther; 2002 Oct; 24(10):1706-17. PubMed ID: 12462298
[TBL] [Abstract][Full Text] [Related]
2. Study design and selection criteria in the BEST study.
Rist T; Davis MW
Cutis; 2003 Feb; 71(2 Suppl):5-9. PubMed ID: 12630669
[TBL] [Abstract][Full Text] [Related]
3. Overall results of the BEST study following treatment of patients with mild to moderate acne.
Weiss J; Shavin J; Davis MW
Cutis; 2003 Feb; 71(2 Suppl):10-7. PubMed ID: 12630670
[TBL] [Abstract][Full Text] [Related]
4. Comparative Trial of Silver Nanoparticle Gel and 1% Clindamycin Gel when Use in Combination with 2.5% Benzoyl Peroxide in Patients with Moderate Acne Vulgaris.
Jurairattanaporn N; Chalermchai T; Ophaswongse S; Udompataikul M
J Med Assoc Thai; 2017 Jan; 100(1):78-85. PubMed ID: 29911775
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy and safety of a combination topical gel formulation of benzoyl peroxide and clindamycin with benzoyl peroxide, clindamycin and vehicle gel in the treatments of acne vulgaris.
Leyden JJ; Berger RS; Dunlap FE; Ellis CN; Connolly MA; Levy SF
Am J Clin Dermatol; 2001; 2(1):33-9. PubMed ID: 11702619
[TBL] [Abstract][Full Text] [Related]
6. The BEST study: evaluating efficacy by selected demographic subsets.
Fernandez-Obregon A; Davis MW
Cutis; 2003 Feb; 71(2 Suppl):18-26. PubMed ID: 12630671
[TBL] [Abstract][Full Text] [Related]
7. Fitzpatrick skin types and clindamycin phosphate 1.2%/benzoyl peroxide gel: efficacy and tolerability of treatment in moderate to severe acne.
Callender VD
J Drugs Dermatol; 2012 May; 11(5):643-8. PubMed ID: 22527435
[TBL] [Abstract][Full Text] [Related]
8. Conjoint analysis: a novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trial.
Kellett N; West F; Finlay AY
Br J Dermatol; 2006 Mar; 154(3):524-32. PubMed ID: 16445786
[TBL] [Abstract][Full Text] [Related]
9. Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel.
Cook-Bolden FE
J Drugs Dermatol; 2012 Apr; 11(4):455-9. PubMed ID: 22453581
[TBL] [Abstract][Full Text] [Related]
10. A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris.
Zaenglein AL; Shamban A; Webster G; Del Rosso J; Dover JS; Swinyer L; Stein L; Lin X; Draelos Z; Gold M; Thiboutot D
J Drugs Dermatol; 2013 Jun; 12(6):619-25. PubMed ID: 23839176
[TBL] [Abstract][Full Text] [Related]
11. Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations.
Lookingbill DP; Chalker DK; Lindholm JS; Katz HI; Kempers SE; Huerter CJ; Swinehart JM; Schelling DJ; Klauda HC
J Am Acad Dermatol; 1997 Oct; 37(4):590-5. PubMed ID: 9344199
[TBL] [Abstract][Full Text] [Related]
12. The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study.
Gonzalez P; Vila R; Cirigliano M
J Cosmet Dermatol; 2012 Dec; 11(4):251-60. PubMed ID: 23174047
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Moderate Acne Vulgaris in Fitzpatrick Skin Type V or VI: Efficacy and Tolerability of Fixed Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% Gel.
Amar L; Kircik LH
J Drugs Dermatol; 2018 Oct; 17(10):1107-1112. PubMed ID: 30365592
[TBL] [Abstract][Full Text] [Related]
14. Clindamycin/benzoyl peroxide gel: a review of its use in the management of acne.
Warner GT; Plosker GL
Am J Clin Dermatol; 2002; 3(5):349-60. PubMed ID: 12069641
[TBL] [Abstract][Full Text] [Related]
15. Solubilized benzoyl peroxide versus benzoyl peroxide/clindamycin in the treatment of moderate acne.
Tanghetti E; Kircik L; Wilson D; Dhawan S
J Drugs Dermatol; 2008 Jun; 7(6):534-8. PubMed ID: 18561583
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
Eichenfield LF; Alió Sáenz AB
J Drugs Dermatol; 2011 Dec; 10(12):1382-96. PubMed ID: 22134562
[TBL] [Abstract][Full Text] [Related]
17. Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Aqueous Gel: Long-Term Use in Adult Females With Moderate Acne Vulgaris.
Kircik LH
J Drugs Dermatol; 2017 Jun; 16(6):543-546. PubMed ID: 28686771
[TBL] [Abstract][Full Text] [Related]
18. The BEST study: results according to prior treatment.
Rodriguez D; Davis MW
Cutis; 2003 Feb; 71(2 Suppl):27-34. PubMed ID: 12630672
[TBL] [Abstract][Full Text] [Related]
19. Clindamycin/benzoyl peroxide gel (BenzaClin): a review of its use in the management of acne.
McKeage K; Keating GM
Am J Clin Dermatol; 2008; 9(3):193-204. PubMed ID: 18429651
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in moderate or severe acne subpopulations.
Webster G; Rich P; Gold MH; Mraz S; Calvarese B; Chen D
J Drugs Dermatol; 2009 Aug; 8(8):736-43. PubMed ID: 19663111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
